Nalaganje...
Sorafenib Improves Survival in Metastatic Hepatocellular Carcinoma: A Case Report
Hepatocellular carcinoma (HCC) is a very common cancer. Curative treatments and local ones are well validated. Sorafenib, a multi-kinase receptor inhibitor was introduced in 2007 for advanced HCC in patients with preserved liver function. HCC is known to be resistant to systemic chemotherapy, and th...
Shranjeno v:
| izdano v: | World J Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elmer Press
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649801/ https://ncbi.nlm.nih.gov/pubmed/29147210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4021/wjon240w |
| Oznake: |
Označite
Brez oznak, prvi označite!
|